due to increased aromatase activity familial gynecomastia

Also Known As:

familial gynecomastia, due to increased aromatase activity; Aromatase Excess Syndrome; Gynecomastia, Familial, due to Increased Aromatase Activity; Gynecomastia, Hereditary

Enzymes and Coenzymes: 1
- Enzymes: 155591
  - Oxidoreductases: 13899
    - Oxygenases: 336
      - Mixed Function Oxygenases: 2207
        Cytochrome P-450 Enzyme System: 5452
        Cytochrome P450 Family 19: 20
        Aromatase: 2880
        due to increased aromatase activity familial gynecomastia: 14
        Steroid Hydroxylases: 11
        Aromatase: 2880
        due to increased aromatase activity familial gynecomastia: 14
- Cytochromes: 2210
  - Cytochrome P-450 Enzyme System: 5452
    - Cytochrome P450 Family 19: 20
      - Aromatase: 2880
        due to increased aromatase activity familial gynecomastia: 14
    - Steroid Hydroxylases: 11
      - Aromatase: 2880
        due to increased aromatase activity familial gynecomastia: 14
Amino Acids, Peptides, and Proteins: 1
- Proteins: 496323
  - Hemeproteins: 196
    - Cytochromes: 2210
      - Cytochrome P-450 Enzyme System: 5452
        Cytochrome P450 Family 19: 20
        Aromatase: 2880
        due to increased aromatase activity familial gynecomastia: 14
        Steroid Hydroxylases: 11
        Aromatase: 2880
        due to increased aromatase activity familial gynecomastia: 14
Skin and Connective Tissue Diseases
- Skin Diseases: 13402
  - Breast Diseases: 1573
    - Gynecomastia: 1485
      - due to increased aromatase activity familial gynecomastia: 14
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 960
- Inborn Genetic Diseases: 12342
  - Inborn Errors Metabolism: 1183
    - due to increased aromatase activity familial gynecomastia: 14
Nutritional and Metabolic Diseases: 15
- Metabolic Diseases: 10634
  - Inborn Errors Metabolism: 1183
    - due to increased aromatase activity familial gynecomastia: 14

Toshinori Nishigaki Selected Research

Toshinori Nishigaki Research Topics

Disease

Drug/Important Bio-Agent (IBA)